Month: December 2023

Significant Health and Quality of Life Improvements Achieved in Children with Achondroplasia Treated for One Year with TransCon™ CNP (Navepegritide) at 100 µg/kg/week

TransCon CNP is the first investigational product to demonstrate improvements in health-related quality of life and disease impacts in children...

Daré Bioscience Announces Positive Topline Pharmacokinetic and Exploratory Efficacy Results from the DARE-PDM1 Phase 1 Clinical Study

Data Support Continued Clinical Development of DARE-PDM1 and its Potential as a First-in-Category Treatment for Primary DysmenorrheaSAN DIEGO, Dec. 20,...

Longeveron Announces Additional Positive Clinical Data and Imaging Biomarker Results from the CLEAR MIND Phase 2a Trial of Lomecel-B™ in the Treatment of Mild Alzheimer’s Disease

New clinical data showed that Lomecel-B™ improved cognitive function in multiple measures in a dose-response fashion Caregiver ratings documented improved quality...

Awakn Life Sciences Enters Global Licensing Agreement For Proprietary Sublingual S-Ketamine Formulation With LTS

Agreement Includes Exclusive Rights for Treatment of Addiction, Anxiety and Eating DisordersAlso Includes Access to Phase 1 Data and Patents...

23-Provider Dermatology Clinic Increases Patient Engagement and Clinic Growth With eClinicalWorks EHR and healow Patient Engagement Solutions

healow Open Access enables digital access for the growing patient population and reduces no-shows at Skin Solutions DermatologyWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®,...

error: Content is protected !!